Great presentation today at the #LegorretaCancerCenter Cancer Biology Program meeting by @KMDaileyPhD,
Assistant Professor, Dept. of Biomedical & Pharmaceutical Sciences, URI
Faculty Scholar, Rhode Island IDeA Network of Biomedical Research
Excellence (RI-INBRE) on “Changing the Paradigm: Developing Clostridium novyi-NT as an Intravenous Pancreatic Cancer
Therapeutic.” @rwsobol
Check out how engineering biology is helping long duration space travel! So excited to have been a part of these efforts with @EngBioRC .
roadmap.ebrc.org/engineering…
Dr. Kaitlin Dailey will be presenting "Changing the Paradigm: Developing Clostridium novyi-NT as an Intravenous metastatic Pancreatic Cancer Therapeutic" at today's Physiology Forum. 11:00 a.m. in the Sorrell Center. @Gundrylab @UNMC_CHVR
#SynBYSS seminar at 10 am USA CDT
No seminar on Nov 9.
104th, Nov 16 with Prof Johan Paulsson @Harvard & Dr Kaitlin Dailey @KMDaileyPhD at University of Nebraska Medical Center @unmc
Zoom link for the general audience: us02web.zoom.us/j/8838050483…
Beyond thrilled to have gotten the award notification for a Loan Repayment Program application this morning! Very excited for the opportunity to work with @NIH_LRP.
Very pleased to release this literature review from a great group of collaborators at Rocky Vista University!
"Hacking the Immune Response to Solid Tumor: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria"
mdpi.com/1999-4923/15/7/2004
Absolutely thrilled to be at the @EngBioRC annual meeting in Chicago! Thanks GMaP region 3 for the travel award. I'm excited to share my research on engineering oncolytic bacteria as cancer therapeutics from @unmc!